Express Scripts Holding Company (ESRX) Expected to Post Quarterly Sales of $25.38 Billion
Wall Street analysts predict that Express Scripts Holding Company (NASDAQ:ESRX) will post $25.38 billion in sales for the current fiscal quarter, according to Zacks. Nine analysts have made estimates for Express Scripts Holding’s earnings. The highest sales estimate is $26.19 billion and the lowest is $24.77 billion. Express Scripts Holding posted sales of $25.22 billion in the same quarter last year, which would indicate a positive year over year growth rate of 0.6%. The firm is scheduled to announce its next earnings report after the market closes on Tuesday, July 25th.
According to Zacks, analysts expect that Express Scripts Holding will report full year sales of $25.38 billion for the current year, with estimates ranging from $99.93 billion to $103.96 billion. For the next year, analysts forecast that the company will post sales of $104.22 billion per share, with estimates ranging from $102.37 billion to $106.85 billion. Zacks’ sales averages are a mean average based on a survey of analysts that that provide coverage for Express Scripts Holding.
Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Monday, April 24th. The company reported $1.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.32 by $0.01. The business had revenue of $24.65 billion for the quarter, compared to analysts’ expectations of $24.95 billion. Express Scripts Holding had a net margin of 3.42% and a return on equity of 25.64%. The business’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.22 earnings per share.
ESRX has been the topic of several research analyst reports. Jefferies Group LLC set a $88.00 price objective on Express Scripts Holding and gave the company a “buy” rating in a research note on Thursday, April 20th. SunTrust Banks, Inc. reissued a “buy” rating on shares of Express Scripts Holding in a research report on Tuesday, April 25th. UBS AG set a $71.00 price target on Express Scripts Holding and gave the stock a “hold” rating in a research report on Tuesday, April 25th. Argus reissued a “hold” rating on shares of Express Scripts Holding in a research report on Wednesday, March 29th. Finally, Edward Jones lowered Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Wednesday, April 26th. Four analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $71.89.
In other news, VP Phyllis S. Anderson sold 1,100 shares of the stock in a transaction on Friday, May 19th. The stock was sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the transaction, the vice president now owns 11,108 shares of the company’s stock, valued at $667,368.64. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.68% of the company’s stock.
Large investors have recently made changes to their positions in the stock. Dodge & Cox bought a new stake in shares of Express Scripts Holding during the fourth quarter valued at approximately $1,456,850,000. Highbridge Capital Management LLC raised its position in shares of Express Scripts Holding by 1,476.0% in the fourth quarter. Highbridge Capital Management LLC now owns 423,411 shares of the company’s stock worth $29,127,000 after buying an additional 396,544 shares in the last quarter. Twin Capital Management Inc. raised its position in shares of Express Scripts Holding by 0.8% in the first quarter. Twin Capital Management Inc. now owns 46,560 shares of the company’s stock worth $3,069,000 after buying an additional 360 shares in the last quarter. Van ECK Associates Corp raised its position in shares of Express Scripts Holding by 28.8% in the first quarter. Van ECK Associates Corp now owns 373,636 shares of the company’s stock worth $24,626,000 after buying an additional 83,568 shares in the last quarter. Finally, Hancock Holding Co. raised its position in shares of Express Scripts Holding by 9.9% in the first quarter. Hancock Holding Co. now owns 183,489 shares of the company’s stock worth $12,094,000 after buying an additional 16,536 shares in the last quarter. 88.47% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/07/23/express-scripts-holding-company-esrx-expected-to-post-quarterly-sales-of-25-38-billion.html.
Shares of Express Scripts Holding (ESRX) traded down 0.22% during mid-day trading on Thursday, hitting $62.50. 2,098,090 shares of the stock traded hands. The stock has a 50 day moving average price of $62.74 and a 200-day moving average price of $65.47. Express Scripts Holding has a one year low of $57.80 and a one year high of $79.24. The company has a market cap of $37.10 billion, a P/E ratio of 11.41 and a beta of 0.90.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.